万古霉素致免疫性血小板减少症的研究进展

被引:13
作者
王学彬
王卓
胡晋红
机构
[1] 第二军医大学长海医院药学部
关键词
万古霉素; 血小板减少症; 免疫性; 不良反应;
D O I
暂无
中图分类号
R978 [治疗传染病及寄生虫病药物];
学科分类号
1007 ;
摘要
万古霉素(vancomycin)是广泛应用于抗感染的糖肽类抗生素,可导致免疫性血小板减少症。该不良反应的发生率虽然不高,但一旦发生可出现严重的致死性出血。本文综述近年国外文献,对此不良反应的临床表现、发病机制及研究进展进行了介绍。
引用
收藏
页码:158 / 161+165 +165
页数:5
相关论文
共 5 条
[1]   An overview of the heparin-induced thrombocytopenia syndrome [J].
Warkentin, TE .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (03) :273-283
[2]   Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis [J].
Visentin, GP ;
Moghaddam, M ;
Beery, SE ;
McFarland, JG ;
Aster, RH .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 138 (01) :22-31
[3]  
Vancomycin‐associated thrombocytopenia: Case report and review of the literature[J] . Janaki C.Kuruppu,Thong P.Le,Carmelita U.Tuazon.Am. J. Hematol. . 1999 (3)
[4]  
Vancomycin-Induced Thrombocytopenia: A Challenge and Rechallenge[J] . Carol E Howard,Lorie A Adams,Jennifer L Admire,Mary A Chu,Ginger L Alred.Annals of Pharmacotherapy . 1997 (3)
[5]  
Patients with quinine- induced immune thrombocytopenia have both"drug- dependent"and"drug-specific"antibodies .2 Bougie DW,Wilker PR,Aster RH. Blood . 2006